4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-26-000045
Chief Financial Officer sold 10,591 shares at $6.82 ($72,227)
From the SEC's structured data for this filing
Trades in this filing
Davis Blaine · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-06 | Sale : show line 1 in the form | −10,591 | $6.82 | $72,227 | 121,220 | D |
| Open-market sales · 10,591 sh · avg $6.82 · $72,227 | ||||||
Loading xslF345X05/wk-form4_1767907186.xml…